DUBLIN (WHTC) – The tug-of-war between generic drug makers Mylan and Perrigo continues. Mylan is making a 34 billion-dollar hostile takeover bid, saying now that they only need just over 50 percent of Perrigo shares, instead of more than 80 percent, to control the Irish-based firm that continues to run its operations from Allegan. Mylan is offering 205 dollars per share; Perrigo’s current stock market price is just under 200 dollars. Perrigo officials call Mylan’s new effort just a “scare tactic” to stockholders.
